Loading...
XSHG600521
Market cap3.42bUSD
Jan 03, Last price  
17.28CNY
1D
-0.52%
1Q
-11.79%
Jan 2017
-5.88%
Name

Zhejiang Huahai Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600521 chart
P/E
30.15
P/S
3.01
EPS
0.57
Div Yield, %
2.22%
Shrs. gr., 5y
2.09%
Rev. gr., 5y
10.28%
Revenues
8.31b
+0.52%
391,129,248423,245,597557,259,616706,981,032801,432,207927,967,0131,022,844,6511,827,614,0152,014,390,9672,296,407,7122,584,987,5663,500,362,0974,092,852,9615,002,002,7175,094,596,2215,388,094,5926,485,213,4176,643,573,1438,265,744,7938,308,719,758
Net income
830m
-28.88%
119,112,019128,912,937110,013,773132,026,144150,066,497164,978,38793,586,510216,905,530341,123,050359,168,439265,500,660442,472,433500,831,356639,246,679107,514,561569,595,139929,815,152487,535,1171,167,758,749830,466,003
CFO
2.22b
+78.40%
163,727,82053,300,72077,542,440136,522,12484,203,195317,436,771299,471,572197,514,841243,829,247490,293,727328,608,722195,314,063433,099,734546,240,88567,895,8401,753,946,2181,555,458,119938,429,8301,242,693,1262,217,021,274
Dividend
Jul 10, 20240.2 CNY/sh
Earnings
May 21, 2025

Profile

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.
URL
https://www.huahaipharm.com/
IPO date
Mar 04, 2003
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,308,720
0.52%
8,265,745
24.42%
Cost of revenue
6,163,423
5,950,545
Unusual Expense (Income)
NOPBT
2,145,297
2,315,200
NOPBT Margin
25.82%
28.01%
Operating Taxes
283,072
332,890
Tax Rate
13.20%
14.38%
NOPAT
1,862,225
1,982,310
Net income
830,466
-28.88%
1,167,759
139.52%
Dividends
(556,006)
(147,282)
Dividend yield
2.60%
0.46%
Proceeds from repurchase of equity
(70,997)
(134,755)
BB yield
0.33%
0.42%
Debt
Debt current
1,582,547
2,168,546
Long-term debt
4,112,060
4,753,614
Deferred revenue
665,441
532,090
Other long-term liabilities
171,025
380,995
Net debt
3,566,934
4,693,834
Cash flow
Cash from operating activities
2,217,021
1,242,693
CAPEX
(1,592,387)
Cash from investing activities
(1,622,771)
Cash from financing activities
(644,174)
609,043
FCF
2,513,588
(362,873)
Balance
Cash
1,435,470
1,508,222
Long term investments
692,204
720,105
Excess cash
1,712,238
1,815,039
Stockholders' equity
6,625,835
6,640,083
Invested Capital
13,025,024
13,307,241
ROIC
14.14%
16.72%
ROCE
14.56%
15.31%
EV
Common stock shares outstanding
1,456,958
1,459,777
Price
14.67
-32.89%
21.86
0.92%
Market cap
21,373,572
-33.02%
31,910,734
1.37%
EV
25,114,770
36,803,639
EBITDA
2,925,669
2,987,210
EV/EBITDA
8.58
12.32
Interest
237,756
220,018
Interest/NOPBT
11.08%
9.50%